Medical History:
A 51-year-old male with an unremarkable cardiovascular history presented with a history of pre-excited atrial fibrillation with a rapid ventricular response reaching up to 300 beats per minute (bpm), first documented 12 years prior. At that time, the patient underwent an electrophysiological study (EPS) and an ablation attempt at another medical center, which was unsuccessful. The patient continued to experience intermittent paroxysmal tachycardias despite ongoing pharmacological therapy with propafenone and a beta-blocker.
Electrocardiogram (ECG) during Sinus Rhythm:
The baseline ECG showed sinus rhythm with a prominent delta wave indicative of a left lateral wall accessory pathway (Figure 1).
ECG of Clinical Tachycardias:
- July 30, 2004: Pre-excited atrial fibrillation with a shortest RR interval of 190 ms. The morphology of pre-excitation was identical to that observed during sinus rhythm, although the degree of pre-excitation during sinus rhythm was significantly less pronounced (Figure 2).
- February 12, 2016: Regular narrow-complex QRS tachycardia at a rate of 200 bpm, demonstrating visible retrograde atrial activation following the termination of the QRS complex; highly suggestive of orthodromic atrioventricular reentrant tachycardia (AVRT) (Figure 3).
- March 13, 2016: Irregular tachycardia presenting with a right bundle branch block (RBBB) morphology (characterized by orthodromic conduction down the normal conduction system) featuring alternating long and short RR intervals (Figure 4). The underlying mechanism was subsequently elucidated during the electrophysiological study.
Electrophysiological Study – Ablation:
Three-dimensional electroanatomical mapping was performed using the Ensite system, supplemented by the EP Workmate Recording System for conventional mapping.
Catheter Placement:
- Quadripolar catheter positioned in the high right atrium (HRA).
- Quadripolar catheter positioned at the His bundle region.
- Quadripolar catheter positioned in the right ventricle (RV).
- Decapolar catheter positioned within the coronary sinus (CS).
- Quadripolar steerable, 3.5mm irrigated-tip ablation/mapping catheter.
Baseline Intervals:AH: 80 ms, HV: 15 ms, QRS: 160 ms (Tracing 1)
Programmed Ventricular Stimulation:
Ventricular pacing demonstrated ventricuoatrial (VA) conduction via the left lateral accessory pathway (Tracing 2).
Programmed Atrial Stimulation:
Incremental atrial pacing from the coronary sinus determined that the anterograde effective refractory period (ERP) of the accessory pathway was < 250 ms, as pacing beyond this threshold induced atrial fibrillation, which spontaneously terminated after 1 minute (Tracings 3, 4).
Programmed single atrial extrastimulus pacing from the proximal coronary sinus (CS 5-6) induced a regular wide-complex QRS tachycardia. The QRS morphology was identical to that of baseline pre-excitation, with a cycle length of 420 ms, a VA interval of 235 ms, and the earliest retrograde atrial activation recorded at the His bundle region. Delivering single atrial extrastimuli when the His bundle was refractory resulted in advancement (pre-excitation) of the ventricular activation (Tracings 5-7). This tachycardia is consistent with antidromic atrioventricular reentrant tachycardia (AVRT).
Concurrently, though less frequently, an orthodromic AVRT was induced, featuring a cycle length of 328 ms, a VA interval of 152 ms, and the earliest retrograde atrial activation recorded at the distal coronary sinus (Tracing 8). Furthermore, an orthodromic AVRT exhibiting alternating conduction down the fast and slow atrioventricular (AV) nodal pathways was also induced (Tracing 9).
Subsequently, retrograde aortic access was obtained to perform mapping along the mitral annulus during sinus rhythm. At the lateral wall, corresponding approximately to the 3 o’clock position on the mitral annulus, a region demonstrating a short AV interval and earliest ventricular activation (V) was identified (Tracing 10, Figure 5).
Radiofrequency (RF) energy was applied at this site (30–60 W, up to 40°C, for 3 minutes), resulting in the immediate elimination of pre-excitation during sinus rhythm (Tracing 11). Subsequent programmed atrial pacing revealed no evidence of anterograde conduction over the accessory pathway (Tracing 12). Retrograde conduction via the pathway was also completely abolished.
Following a continuous infusion of isoproterenol, repeat programmed stimulation maneuvers failed to induce any form of tachycardia (Tracings 13, 14).
Post-procedural Course:
The procedure was uncomplicated. The patient was mobilized the following day. A post-procedural ECG obtained the evening after the ablation demonstrated complete resolution of pre-excitation alongside a mechanical RBBB (Figure 6). The following day’s ECG showed resolution of pre-excitation along with clearance of the RBBB (Figure 7).
Commentary:
This case involves a patient with a manifest left lateral accessory pathway who demonstrated four distinct types of tachycardia during the electrophysiological study, three of which had been clinically documented:
- Pre-excited atrial fibrillation with an extremely rapid ventricular response due to the short effective refractory period of the accessory pathway.
- Antidromic AVRT utilizing the accessory pathway.
- Orthodromic AVRT utilizing the accessory pathway.
- Orthodromic AVRT utilizing the accessory pathway with alternating conduction via the slow and fast AV nodal pathways.
Due to the presence of dual AV nodal pathways, the patient could theoretically have developed a fifth type of arrhythmia: atrioventricular nodal reentrant tachycardia (AVNRT). However, this could not be induced despite aggressive programmed stimulation and intravenous isoproterenol infusion.
Evidently, pre-excited atrial fibrillation carried the highest clinical risk. According to international guidelines established as early as 2003, catheter ablation is designated as the first-line and sole definitive treatment of choice. The failure of the initial ablation attempt at the primary center should have prompted an immediate referral to a high-volume, experienced electrophysiology center. Nonetheless, the initiation of pharmacological therapy with propafenone and a beta-blocker likely provided partial protection against severe arrhythmic events over several years. However, due to the short half-life of propafenone and the dynamic nature of the electrophysiological properties of accessory pathways, medical therapy cannot be considered a reliable strategy for long-term risk reduction. Conversely, successful catheter ablation permanently eradicates the risk of sudden cardiac events.
Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7














References
- ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias. Blomström-Lundqvist C, Scheinman MM, Aliot EM et al. J Am Coll Cardiol. 2003;2(8):1493-531